Halving heart failure outcomes by finerenone-mediated type 2 diabetes prevention. Journal Articles

Overview
Research
Identity
Additional Document Info
View All

authors

Gerstein, Hertzel Chaim
Mohammedi, Kamel

status

published

publication date

February 2025

has subject area

1101 Medical Biochemistry and Metabolomics (FoR)
1103 Clinical Sciences (FoR)
1117 Public Health and Health Services (FoR)

published in

The Lancet Diabetes and Endocrinology Journal